The Chronic Angioedema Registry: what the first 2 years since the implementation of the global registry have taught us.
A new international registry captures how chronic angioedema actually affects patients, providing crucial data infrastructure for improving diagnosis and treatment.
CARE is the first international multicenter observational registry specifically designed to capture clinical and patient-reported outcomes across all types of chronic angioedema—a condition that is significantly underdiagnosed and undertreated due to diagnostic complexity and diverse etiologies. The 2-year enrollment report establishes an important evidence infrastructure for a rare disease population and provides preliminary epidemiologic characterization to support future therapeutic trial design and outcome standardization.
What the study was
- Study design
- International multicenter prospective observational registry (CARE registry; 2-year enrollment report)
- Population
- Patients with recurrent angioedema of any type enrolled across international centers
- Category
- Public Health
- Maturity
- Exploratory
- Journal
- Frontiers in allergy
Why it surfaced
First systematic international registry for chronic angioedema establishes clinical evidence infrastructure for a rare disease population with diagnostic and therapeutic unmet needs; registry data will underpin future evidence-based management.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.